The ability to rapidly secrete cytokines upon stimulation is a functional characteristic of the invariant natural killer T (iNKT) cell lineage. iNKT cells are therefore characterized as an innate T cell population capable of activating and steering adaptive immune responses. The development of improved techniques for the culture and expansion of murine iNKT cells facilitates the study of iNKT cell biology in in vitro and in vivo model systems. Here we describe an optimized procedure for the isolation and expansion of murine splenic iNKT cells.
Introduction
Murine invariant natural killer T (iNKT) cells are a distinct population of innate T lymphocytes selected in the thymus by CD1d-expressing cortical thymocytes 1, 2 . iNKT cells express a T cell receptor (TCR) comprised of an invariant Vα14-Jα18 TCR chain paired with either Vβ8, Vβ7 or Vβ2 TCRs 3 , which is capable of recognizing endogenous as well as foreign lipid antigens in the context of CD1d. For example, murine iNKT cells recognize and are activated by an endogenous lipid antigen called isoglobotrihexosylceramide (iGb3) 4 , as well as α-galactosylceramide (αGalCer) 5, 6 , a glycolipid isolated from marine sponges. TCR-dependent activation of iNKT cells promotes the priming of adaptive immune responses, and as a result, iNKT cells have been shown to be functionally involved in the amelioration or development of a range of pathologies including rheumatic disease 7 and cancer 8 . Currently, synthetic iNKT cell ligands constitute promising new vaccine adjuvants that may be capable of regulating a number of immunopathological conditions. It has previously been demonstrated that iNKT cells can be generated in vitro following isolation from mouse tissue however; many of these studies employ the use of primary antigen-presenting cells (APCs) and/or cell lines 9 , Vα14 TCR transgenic (Tg) mice 10 , or thymomas for the generation of iNKT cell-derived hybridomas 11, 12 . Furthermore, large numbers of mice, high volumes of reagents such as αGalCer-loaded CD1d dimers, and lengthy culture times make some published protocols less ethically and economically appealing 9, 13 . In this report we describe an adapted method for the isolation and in vitro expansion of iNKT cells from mouse spleen. More specifically, the protocol describes a method for enriching iNKT cells from mouse spleen which reduces the mice, reagents and time required for FACS cell sorting, and proposes an optimized approach for expanding sorted splenic iNKT cells in vitro. + lymphocytes as shown in Figure   1D . Acquire the remainder of the pre-enriched sample on the flow cytometer. 1. Coat a flat-bottomed 96 well plate with purified anti-CD3ε (3 µg/ml) per well for 1 hr at RT. Wash twice with 200 µl 1x PBS and once with 200 µl complete RPMI 1640 medium (10% vol/vol FCS, 100 U/ml penicillin-streptomycin, 5.5 µM β-mercaptoethanol). 2. Count the number of viable sorted iNKT cells (step 2.2.8) using 0.4% a hemocytometer as in 1.11., centrifuge at 300 x g for 10 min at 4 °C and resuspend at 5 x 10 5 cells/ml in complete RPMI 1640 medium containing recombinant murine IL-2 (10 ng/ml), recombinant murine IL-12
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(1 ng/ml) and soluble anti-mouse CD28 (5 µg/ml). Plate sorted iNKT cells at 10 5 cells/well in anti-CD3ε coated plates and incubate at 37 °C in a CO 2 incubator for 2 days. 
Representative Results
Isolation of splenic mononuclear cells using a density gradient takes approximately 1 hr and eliminates the use of reagents required to lyse red blood cells (RBCs). A high yield of viable cells is obtained using this method and debris generated during straining of the organ is removed. Typically, the frequency of iNKT cells within the splenic lymphocyte pool ranges between 1 and 5% of total T lymphocytes however, this can vary depending on the age, sex and health status of the animals used. Approximately 10 6 iNKT cells can be acquired from the pooled spleens of 3 mice and the highest yield of iNKT cells are obtained from spleens of 6-8 week old mice.
The use of mouse anti-CD5 magnetic beads significantly enriches for iNKT cells within the splenic MNC fraction and, apart from a minor population of B lymphocytes that express the CD5 antigen, the majority of cells isolated using this procedure constitute CD5 + lymphocytes. For example, 5-8% of the MNCs obtained after CD5 enrichment are CD5-negative ( Figure 1H ). For iNKT cell FACS sorting, combining αGalCer/ CD1d tetramer and anti-mouse CD3ε yields iNKT cell purities above 98% however, FACS dump channels for splenic B and CD8 T cells should be used to eliminate 'sticky' lymphocyte populations during the sort. In addition, gate out any doublets that may have formed during the CD5 enrichment step. Using this FACS setup, we obtained iNKT cell purities post-sort in the order of 99% ( Figure 2H ). 
Discussion
Critical steps in the current protocol include the isolation and subsequent enrichment of CD5 + lymphocytes (Section 1 & 2), FACS sorting (Section 3) and the initial plating of iNKT cells (Section 4). Of the steps performed in Section 1, remember to carefully layer the splenic cellular suspension over the density gradient medium such that a distinct cellular interphase is generated following centrifugation. The subsequent enrichment for CD5 + lymphocytes by magnetic cell separation (Section 2) minimizes the reagents and time required to stain for and FACS sort iNKT cells (Section 3), which helps increase iNKT cell yields post-sort. Finally, it is important to seed no more than 10 5 iNKT cells per well for the first 2 days of culture (Section 4) as seeding wells with higher numbers of iNKT cells can result in cellular apoptosis.
A number of considerations are important when modifying and/or troubleshooting this protocol: Firstly, the age of the animals used is important. Animals that are either too old, or have accessory infections, may hamper your ability to isolate, distinguish, and FACS sort sufficient cells from the spleen. Secondly, when staining with αGalCer/CD1d tetramers, it is important to keep the volume of cells resuspended in PBS buffer low as too high a volume dilutes out the staining efficiency of the αGalCer/CD1d tetramer, which in turn reduces the clustering of tetramer + iNKT cells by FACS. Ideally, the presence of tightly clustered αGalCer/CD1d tetramer + iNKT cells during FACS acquisition allows for more accurate gating by FACS and yields higher percentage purity iNKTs during post-sort analysis. This is important as lower sorted iNKT cell yields will result in the outgrowth of other contaminating T cell populations during culture. Thirdly, continuously refresh medium that becomes yellow during the culture and expansion of iNKT cells. For example, replace 50% of yellowed medium with new medium containing the appropriate cytokines, particularly during days 8 and day 11 of culture. iNKT cell yields can be maximized in this way.
To our knowledge this is the first iNKT expansion protocol to include a density gradient and CD5 + lymphocyte enrichment step for the isolation and enrichment of iNKT cells from mouse spleen. A number of alternative approaches have been explored to enrich for splenic iNKT cells including αGalCer/CD1d dimers 13 , Vα14 TCR Tg mice 10 as well as depletion of non-T cells by magnetic cell separation 9 . However, although iNKT cells can be successfully expanded in vitro using these approaches, such methods require either large volumes of αGalCer/CD1d dimers to enrich for iNKTs 13 , only generate transgenic iNKT cells 10 , or simultaneously give rise to some non-iNKT cell lines 9 . Furthermore, the use of plate-bound anti-CD3ε to maintain and expand sorted iNKT cells (Section 4) precludes a requirement for activated APCs during iNKT expansion in vitro 9 . In this context, an APC-free iNKT expansion protocol has the advantage of not having to separate APCs from expanded iNKT cells prior to injection in vivo. We should however also add that the protocol described is limited by the fact that the investigator requires easy access to, as well as the relevant training, to calibrate and operate a FACS sorter. Unfortunately FACS sorters are expensive and they are not always available in every laboratory. Nevertheless, although the current protocol has been optimized to isolate and culture murine iNKT cells, the enrichment steps described herein can also be used to isolate and study iNKT recent thymic emigrants (RTEs) 16 and can be adapted to enrich for and characterize other rare T cell populations by FACS.
Collectively, we define an optimized approach that can be used to efficiently generate up to 10 8 iNKT cells from the spleens of three mice within 3 weeks. iNKT cells generated in this manner retain the ability to secrete cytokines upon stimulation, making them useful for adoptive transfer experiments and the study of iNKT cell biology in vivo.
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